Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterising Early Response to Neoadjuvant Chemotherapy With Quantitative Breast MRI

NCT02449824 is registered in ClinicalTrials.gov with University of Leeds as lead sponsor.

NCT NCT02449824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02449824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterising Early Response to Neoadjuvant Chemotherapy With Quantitative Breast MRI
Lead sponsor
University of Leeds
Phase
Observational
Overall status
Completed
Start date
July 31, 2015
Completion date
Not reported
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms